Mutations In Emp2 Cause Childhood-Onset Nephrotic Syndrome
Göster/ Aç
Tarih
2014Yazar
Gee, Heon Yung
Ashraf, Shazia
Wan, Xiaoyang
Vega-Warner, Virginia
Esteve-Rudd, Julian
Lovric, Svjetlana
Fang, Humphrey
Hurd, Toby W.
Sadowski, Carolin E.
Allen, Susan J.
Otto, Edgar A.
Korkmaz, Emine
Washburn, Joseph
Levy, Shawn
Williams, David S.
Bakkaloglu, Sevcan A.
Zolotnitskaya, Anna
Ozaltin, Fatih
Zhou, Weibin
Hildebrandt, Friedhelm
Üst veri
Tüm öğe kaydını gösterÖzet
Nephrotic syndrome (NS) is a genetically heterogeneous group of diseases that are divided into steroid-sensitive NS (SSNS) and steroid-resistant NS (SRNS). SRNS inevitably leads to end-stage kidney disease, and no curative treatment is available. To date, mutations in more than 24 genes have been described in Mendelian forms of SRNS; however, no Mendelian form of SSNS has been described. To identify a genetic form of SSNS, we performed homozygosity mapping, whole-exome sequencing, and multiplex PCR followed by next-generation sequencing. We thereby detected biallelic mutations in EMP2 (epithelial membrane protein 2) in four individuals from three unrelated families affected by SRNS or SSNS. We showed that EMP2 exclusively localized to glomeruli in the kidney. Knockdown of emp2 in zebrafish resulted in pericardial effusion, supporting the pathogenic role of mutated EMP2 in human NS. At the cellular level, we showed that knockdown of EMP2 in podocytes and endothelial cells resulted in an increased amount of CAVEOLIN-1 and decreased cell proliferation. Our data therefore identify EMP2 mutations as causing a recessive Mendelian form of SSNS.